03.07.2024 | Published by Genetic Engineering & Biotechnology News

Exclusive interview with Genetic Engineering & Biotechnology News

Featured Image

CEO Mark Kotter shares insights in an exclusive interview with Genetic Engineering & Biotechnology News about bit.bio's revolutionary CNS Tool Kit, a game-changer for CNS research and drug discovery.

Key Highlights:

Approach: Kotter discusses the shift from traditional directed differentiation methods to deterministic cell programming, significantly speeding up the process of creating human brain cells.

opti-ox: bit.bio’s proprietary deterministic programming technology allows for the rapid and consistent production of various brain cell types, including the newly launched ioAstrocytes, complementing the existing ioCells portfolio.

Building Brain Models: these cells can be combined to create detailed and customisable brain models, facilitating the study of cell interactions and disease mechanisms in a human context. ioAstrocytes and other brain cells can be co-cultured to facilitate brain complexity and disease mechanism modeling.

Access the article here


Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs